Virax Biolabs Group Ltd (NASDAQ:VRAX) has a beta value of 1.67 and has seen 2.01 million shares traded in the last trading session. The company, currently valued at $13.50M, closed the last trade at $3.11 per share which meant it gained $0.68 on the day or 27.98% during that session. The VRAX stock price is -189.39% off its 52-week high price of $9.00 and 80.71% above the 52-week low of $0.60. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.57 million shares traded. The 3-month trading volume is 1.80 million shares.
Virax Biolabs Group Ltd (NASDAQ:VRAX) trade information
Sporting 27.98% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VRAX stock price touched $3.11 or saw a rise of 2.81%. Year-to-date, Virax Biolabs Group Ltd shares have moved 38.22%, while the 5-day performance has seen it change 48.10%. Over the past 30 days, the shares of Virax Biolabs Group Ltd (NASDAQ:VRAX) have changed 78.74%. Short interest in the company has seen 0.45 million shares shorted with days to cover at 0.11.
Virax Biolabs Group Ltd (VRAX) estimates and forecasts
The company’s shares have gained 159.17% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -52.25% over the past 5 years.
VRAX Dividends
Virax Biolabs Group Ltd is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Virax Biolabs Group Ltd (NASDAQ:VRAX)’s Major holders
The top two institutional holders are VIRTU FINANCIAL LLC with over 28058.0 shares worth more than $33000.0. As of 2024-06-30, VIRTU FINANCIAL LLC held 1.3984% of shares outstanding.
The other major institutional holder is HRT FINANCIAL LP, with the holding of over 25672.0 shares as of 2024-06-30. The firm’s total holdings are worth over $29000.0 and represent 1.2795% of shares outstanding.
